The purpose of this study was to investigate the dose response effect of Bifidobacterium lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
100
Bifidobacterium lactis HN019, 10 billion cfu/day, once a day for 14 days
Bifidobacterium lactis HN019, 1 billion cfu/day, once a day for 14 days
Placebo, once a day for 14 days
Colonic transit time
Time frame: 14 days
Gastrointestinal symptoms
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.